Back to Walleye Capital LLC Walleye Capital LLC

ANIPANIP
Showing 8 of 18 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in Ani Pharmaceuticals Inc

Yes. Walleye Capital holds 106,112 shares of ANIP (Ani Pharmaceuticals), worth $8.8M, as of its Q2 2026 13F filing. It reduced the position by 76,963 shares (-42.0%) from Q1 2026. Walleye Capital has held ANIP since Q4 2024, across 7 quarterly 13F filings.

Current Value

$8.8M

Current Shares

106,112

Total Value Change

+$8.8M

Total Shares Change

+106,112

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
106,112
-42.0%
$8.8M0.0%$82.78
0
2026-Q1
Increased
183,075
+56.1%
$14.1M0.1%$76.90
40
2025-Q4
Decreased
117,307
-45.8%
$9.3M0.0%$78.94
0
2025-Q3
Increased
216,307
+531.2%
$19.8M0.1%$91.60
46
2025-Q2
Increased
34,267
+9.5%
$2.2M0.0%$65.25
29
2025-Q1
Decreased
31,284
-56.6%
$2.1M0.0%$66.95
0
2024-Q4
New
72,009
-
$4M0.0%$55.28
37
2024-Q3
Exited
0
-100.0%
$00.0%$59.66
0

Other major holders of ANIP: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used